Creating animation is a time-consuming process, requiring multiple steps, including storyboarding, rendering, composition, and lighting to craft a single scene. If a director wants to experiment ...

Fox’s Animation Block, which normally airs on Sundays, is opening a temporary summer block on Thursdays, kicking off May 29 with Bob’s Burgers at 8 pm, followed by Grimsburg at 8:30 pm ...

Universal Pictures has set a theatrical release date for DreamWorks Animation’s “Forgotten Island.” The animated feature will be released on Sept. 25, 2026. Joel Crawford and Januel Mercado ...

EXCLUSIVE: Indonesian animated feature Jumbo has become the highest-grossing Southeast Asian animation of all time. Produced by Visinema Studios, the film has earned over $8M at the Indonesian box ...

Celon Pharma’s PDE10A inhibitor has reduced involuntary movements in a phase 2 trial of individuals with Parkinson’s disease. The Polish biotech tested two daily doses of the drug, dubbed CPL ...

A groundbreaking study led by researchers at Insilico Medicine has revealed the potential of TNIK inhibition as an innovative anti-aging strategy. Using an AI-driven robotics laboratory , the team ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression. A national study ...

For a while there, it seemed like a crudely drawn webcomic had DreamWorks Animation’s number. In an unflattering contrast to the imaginative movies that Pixar was making in the ‘00s ...

Netflix continues to lead the way with their feature animation output, which currently stands at seven animated releases for 2025, including their first Korean-language animated film (Lost in ...

The decision to discontinue BTK inhibitor treatment for CLL is complex, with emerging data suggesting that time-limited therapy may be feasible in certain cases, particularly when combined with other ...

Cobimetinib plus atezolizumab for RAS and NF1/2-mutated poorly differentiated thyroid carcinoma. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a ...

Minimal residual disease by circulating tumor DNA as a biomarker of recurrence free survival in resected high-risk melanoma patients treated with mRNA-4157/V940, a personalized cancer vaccine, and ...